Direct emissions
124,340
tCO2e
U
United Drug
Explore carbon emissions data for United Drug. Mycelium helps you review reported emissions, disclosure status, Scope 1, Scope 2 and Scope 3 data, climate targets and sustainability information in one company profile.
This profile brings together available carbon emissions data for United Drug, including reported figures, modelled estimates, disclosure documents and sustainability indicators, so you can review its emissions and compare its performance against similar companies. Read how we source and check this data.
Emissions
Carbon emissions
Total yearly emissions across all scopes
763,012 tCO2e (Market Based)
Scope 1
tCO2e
124,340
Scope 2 (Market Based)
tCO2e
78
Scope 3 total
tCO2e
638,594
Scope 3 reported
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Provenance
Emissions
Factors
614,812
kgCO2e / £M
Supplier specific emission factors (kgCO2e / £M)
Modelled
Reported
Scope 1 + 2
Direct + purchased energy
100,253
100,253
Upstream
+ upstream Scope 3
454,644
451,025
Total
+ all Scope 3
614,812
451,025
Which figure should I use?
Use Modelled. It is the most complete view: any categories the company hasn't disclosed are filled with industry-typical estimates, so a transparent company isn't unfairly penalised against one that simply hasn't reported.
Reported counts only emissions the company has filed itself. A blank or low Reported cell doesn't mean those emissions don't exist, just that the company hasn't disclosed them.
When Reported sits close to Modelled, that is a positive signal. The company has disclosed most of its salient emissions and there's little gap for the model to fill. Even then, Modelled is the right figure to use for a like-for-like comparison across companies.
Sustainability
Snapshot
Based on reported data, retrieved with AI
- United Drug reported 763,012 tCO₂e in 2025.
- Scope 3 accounted for 84% of emissions.
- Reported across 7 of 15 GHG Protocol Scope 3 categories.
- Scope 2 reported under the market based methodology.
According to available emissions disclosures, United Drug reported total yearly emissions of 763,012 tCO₂e in 2025. Scope 3 emissions accounted for 84% of reported output, indicating supply chain activity, purchased goods and services, business travel, and wider operational dependencies were the most significant contributors to the company's carbon footprint.
The company achieved a Mycelium Score of 1.6, placing it well below average for its sector for sustainability performance, and received a transparency score of 47.9, pointing to fairly limited disclosure, with notable gaps in key areas.
Total Emissions across all scopes
763,012 tCO2e (Market Based)
Scope 1 emissions
Direct emissions from sources the company owns or controls, such as fuel use, facilities and vehicles.
Scope 2 emissions
Indirect emissions from purchased energy, including electricity, heating and cooling.
Location based
140,878
tCO2eMarket based
78
tCO2eScope 3 emissions
Wider value chain emissions across the 15 GHG Protocol categories, from purchased goods and business travel to investments, where reported.
Cat 1
Purchased goods & services
239,757
tCO2eCat 2
Capital goods
106,250
tCO2eCat 3
Fuel & energy related activities
54,203
tCO2eCat 4
Upstream transportation & distribution
8
tCO2eCat 5
Waste generated in operations
28,357
tCO2eCat 6
Business travel
1,503
tCO2eCat 7
Employee commuting
5,248
tCO2eCat 8
Upstream leased assets
4,491
tCO2eCat 9
Downstream transportation & distribution
4,491
tCO2eCat 10
Processing of sold products
4,491
tCO2eCat 11
Use of sold products
171,830
tCO2eCat 12
End-of-life treatment of sold products
4,491
tCO2eCat 13
Downstream leased assets
4,491
tCO2eCat 14
Franchises
4,491
tCO2eCat 15
Investments
4,491
tCO2e8 values were derived via Mycelium's normalisation process rather than reported by the company. Cells marked “–” were not disclosed.
Contact Info
Browse carbon emissions data by industry
Jump straight into the sectors users explore most, or view all industries.
How scoring works
How the Mycelium Score is calculated
The Mycelium Score is out of 10. Up to 6.5 points reflect carbon intensity vs sector peers (emissions normalised against revenue). The remaining 3.5 reflect data quality: third-party verified, profile claimed by the company, and full disclosure across all reporting categories.
A higher score means lower carbon intensity than sector peers, backed by data that's third-party verified, claimed by the company, and fully disclosed. United Drug's score sits at the top of this page and in the score panel.
How the Transparency Score is calculated
The Transparency Score measures how much of a company's key emissions data is publicly disclosed, graded from A (very high) down to F (very low). Crucially, it weights each gap by how material that bucket is for the company's industry, so an undisclosed category where the bulk of emissions sit hurts far more than a minor one.
For United Drug, the single biggest gap is Use of sold products (Scope 3 Category 11). Mycelium estimates it accounts for around 23% of the company's total footprint, typically the largest source of emissions for a Retail company, yet it hasn't been disclosed. Leaving a bucket this large unreported is what's holding the transparency score down.
In total, roughly 23% of United Drug's estimated emissions sit in categories it hasn't reported. Disclosing these would be the fastest way to raise the transparency score.
Read the full scoring methodology
Our white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10.
Download the white paper (PDF)
United Drug carbon emissions FAQs
What are United Drug's carbon emissions?
In its 2025 reporting year, United Drug disclosed total emissions of 763,012 tCO2e across all scopes. Scope 3 accounted for the largest share, around 84% of the total.
Does United Drug report Scope 1, Scope 2 and Scope 3 emissions?
For 2025, United Drug's available disclosure covers Scope 1 (124,340 tCO2e), Scope 2 (78 tCO2e), Scope 3 across 7 of the 15 GHG Protocol categories. Figures not reported by the company are shown as modelled estimates and labelled as such.
How transparent is United Drug's emissions reporting?
United Drug has a Mycelium transparency score of 47.9 out of 100. The score weights each emissions category by how material it is for the company's industry, so it reflects whether the disclosures that matter most have been made.
Is United Drug sustainable?
Mycelium measures sustainability through carbon emissions data rather than giving a yes or no verdict. United Drug has a Mycelium Score of 1.6 out of 10, which reflects its emissions intensity against sector peers together with how transparent and well-verified its reporting is. The emissions figures, disclosure documents and climate targets on this page give the fuller picture.
Is United Drug environmentally friendly?
Carbon emissions are one measurable part of environmental impact, and the part Mycelium tracks. United Drug disclosed 763,012 tCO2e for 2025, and its Mycelium Score of 1.6 out of 10 shows how that performance compares with similar companies in its sector.
Learn more about our methodology and where this data comes from.
